Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Immunol ; 183(6): 4013-20, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19717523

ABSTRACT

Eosinophil granule proteins are deposited in cutaneous lesions in many human diseases, but how these proteins contribute to pathophysiology is obscure. We injected eosinophil cationic protein (ECP or RNase 3), eosinophil-derived neurotoxin (EDN or RNase 2), eosinophil peroxidase (EPO), and major basic protein-1 (MBP1) intradermally into guinea pig and rabbit skin. ECP and EDN each induced distinct skin lesions at >or=2.5 microM that began at 2 days, peaking at approximately 7 days and persisting up to 6 wk. These lesions were ulcerated (ECP) or crusted (EDN) with marked cellular infiltration. EPO and MBP1 (10 microM) each produced perceptible induration and erythema with moderate cellular infiltration resolving within 2 wk. ECP and EDN localized to dermal cells within 2 days, whereas EPO and MBP1 remained extracellular. Overall, cellular localization and RNase activity of ECP and EDN were critical for lesion formation; differential glycosylation, net cationic charge, or RNase activity alone did not account for lesion formation. Ulcerated lesions from patients with the hypereosinophilic syndrome showed ECP and EDN deposition comparable to that in guinea pig skin. In conclusion, ECP and EDN disrupt skin integrity and cause inflammation. Their presence in ulcerative skin lesions may explain certain findings in human eosinophil-associated diseases.


Subject(s)
Eosinophil Granule Proteins/toxicity , Eosinophils/enzymology , Ribonucleases/toxicity , Skin Diseases/etiology , Animals , Eosinophil Cationic Protein/administration & dosage , Eosinophil Cationic Protein/toxicity , Eosinophil Granule Proteins/administration & dosage , Eosinophil Major Basic Protein/administration & dosage , Eosinophil Major Basic Protein/toxicity , Eosinophil Peroxidase/administration & dosage , Eosinophil Peroxidase/toxicity , Eosinophil-Derived Neurotoxin/administration & dosage , Eosinophil-Derived Neurotoxin/toxicity , Eosinophilia/pathology , Guinea Pigs , Humans , Rabbits , Ribonucleases/administration & dosage , Skin Diseases/pathology , Ulcer/etiology
2.
J Immunol ; 168(2): 890-9, 2002 Jan 15.
Article in English | MEDLINE | ID: mdl-11777987

ABSTRACT

To investigate the role of HLA-DQ molecules and/or CD4(+) T cells in the pathogenesis of allergic asthma, we generated HLA-DQ6 and HLA-DQ8 transgenic mice lacking endogenous class II (Abeta(null)) and CD4 genes and challenged them intranasally with short ragweed allergenic extract (SRW). We found that DQ6/CD4(null) mice developed a strong eosinophilic infiltration into the bronchoalveolar lavage and lung tissue, while DQ8/CD4(null) mice were normal. However, neither cytokines nor eosinophil peroxidase in the bronchoalveolar lavage of DQ6/CD4(null) mice was found. In addition, the airway reactivity to methacholine was elevated moderately in DQ6/CD4(null) mice compared with the high response in DQ/CD4(+) counterparts and was only partially augmented by CD4(+) T cell transfer. The DQ6/CD4(null) mice showed Th1/Th2-type cytokines and SRW-specific Abs in the immune sera in contrast to a direct Th2 response observed in DQ6/CD4(+) mice. The proliferative response of spleen mononuclear cells and peribronchial lymph node cells demonstrated that the response to SRW in DQ6/CD4(null) mice was mediated by HLA-DQ-restricted CD4(-)CD8(-)NK1.1(-) T cells. FACS analysis of PBMC and spleen mononuclear cells demonstrated an expansion of double-negative (DN) CD4(-)CD8(-)TCRalphabeta(+) T cells in SRW-treated DQ6/CD4(null) mice. These cells produced IL-4, IL-5, IL-13, and IFN-gamma when stimulated with immobilized anti-CD3. IL-5 ELISPOT assay revealed that DN T cells were the cellular origin of IL-5 in allergen-challenged DQ6/CD4(null) mice. Our study shows a role for HLA-DQ-restricted CD4(+) and DN T cells in the allergic response.


Subject(s)
Allergens/immunology , CD4 Antigens/genetics , Gene Deletion , HLA-DQ Antigens/genetics , Respiratory Hypersensitivity/genetics , Respiratory Hypersensitivity/immunology , Allergens/administration & dosage , Animals , Antibodies/blood , Antibody Specificity/genetics , Bronchial Hyperreactivity/genetics , Bronchial Hyperreactivity/immunology , Bronchial Hyperreactivity/pathology , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Crosses, Genetic , Cytokines/biosynthesis , Cytokines/blood , Epitopes/blood , Humans , Injections, Intraperitoneal , Lung/pathology , Lung/physiopathology , Lymphocyte Activation/genetics , Mice , Mice, Transgenic , Plant Extracts/administration & dosage , Plant Extracts/immunology , Respiratory Hypersensitivity/pathology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...